Viewing Study NCT02585804


Ignite Creation Date: 2025-12-24 @ 7:58 PM
Ignite Modification Date: 2026-05-17 @ 5:30 PM
Study NCT ID: NCT02585804
Status: COMPLETED
Last Update Posted: 2018-01-16
First Post: 2015-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects
Sponsor: University Health Network, Toronto
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Focal Segmental Glomerulosclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None FSGS, SGLT2, chronic kidney disease, GFR, proteinuria View